FDA.reportPublic FDA data

betaine Powder for Oral Solution [Cystadane]

RxCUI
1806656
RxNorm name
betaine Powder for Oral Solution [Cystadane]
Term type
SBDF
Status
Active
Updated
2026-10-26 03:53:48

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102016
Active start
102016
Multiple ingredient
NO
Branded
YES

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Powder for Oral Solution1540455

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
betaine1512

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbetaine Powder for Oral Solution [Cystadane]1NAMES
RxNorm Namebetaine Powder for Oral Solution [Cystadane]1NAMES
TTYSBDF1ATTRIBUTES
RxCUI18066561CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA16AAAmino acids and derivativesATC1-4betaine
FDASPLN0000175805Methylating AgentEPChas_epcbetaine
FDASPLN0000175804Methylating ActivityMOAhas_moabetaine
MEDRTD001622BetaineCHEMhas_ingredientbetaine
MEDRTD004342Drug HypersensitivityDISEASEci_withbetaine
MEDRTD006712HomocystinuriaDISEASEmay_treatbetaine
MEDRTN0000009065Hematologic Activity AlterationPEhas_pebetaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS